StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Kazia Therapeutics's total debt was A$98.81K at Dec 31, 2025. For fiscal 2025 it was A$395.64K, down 37.6% from the year before. The highest annual figure on record is A$1.84M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$395.64K-37.6%
FY2024Jun 30, 2024A$634.00K-64.7%
FY2023Jun 30, 2023A$1.80M-2.4%
FY2022Jun 30, 2022A$1.84M–
FY2021Jun 30, 2021A$0–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025A$98.81K-72.5%
Q4 FY2025CQ2 2025Jun 30, 2025A$395.64K-78.0%
Q2 FY2025CQ4 2024Dec 31, 2024A$140.74K-74.5%
Q4 FY2024CQ2 2024Jun 30, 2024A$634.00K-65.6%
Q2 FY2024CQ4 2023Dec 31, 2023A$359.30K–
Q4 FY2023CQ2 2023Jun 30, 2023A$1.80M–
Q2 FY2023CQ4 2022Dec 31, 2022A$552.32K–
Q4 FY2022CQ2 2022Jun 30, 2022A$1.84M–
Q4 FY2021CQ2 2021Jun 30, 2021A$0–

More Kazia Therapeutics figures

See a number that looks wrong?